Cargando…
Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock
INTRODUCTION: Sepsis-associated encephalopathy (SAE) is a diffuse cerebral dysfunction induced by the immuno-inflammatory response to infection. Elevated levels of the brain-specific S100B protein are present in many septic patients and reflect the severity of SAE. Adjunctive treatment with drotreco...
Autores principales: | Spapen, Herbert, Nguyen, Duc Nam, Troubleyn, Joris, Huyghens, Luc, Schiettecatte, Johan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887172/ https://www.ncbi.nlm.nih.gov/pubmed/20374626 http://dx.doi.org/10.1186/cc8947 |
Ejemplares similares
-
Cortisol Is an Associated-Risk Factor of Brain Dysfunction in Patients with Severe Sepsis and Septic Shock
por: Nguyen, Duc Nam, et al.
Publicado: (2014) -
Introduction: severe sepsis and drotrecogin alfa (activated)
por: Artigas, Antonio, et al.
Publicado: (2007) -
Clinical trials in severe sepsis with drotrecogin alfa (activated)
por: Laterre, Pierre-François
Publicado: (2007) -
Timing of drotrecogin alfa (activated) treatment in severe sepsis
por: Choi, Goda, et al.
Publicado: (2006) -
Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain
por: Mohamed, H, et al.
Publicado: (2007)